FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Early intervention benefits patients with MS


























Image Source: MYATTORNEYGREG

Early treatment has long-lasting effects on MS activity, researchers found in a study published in the Aug. issue of Neurology, a medical journal from the American Academy of Neurology. According to a Newswise press release, researchers studied 468 patients randomly assigned to receive either early treatment or placebo.

After participants were diagnosed with MS or after two years, the participants could switch from placebo to an interferon beta-1b drug or something similar, the press released stated. After 11 years, researchers reevaluated the 278 who remained in the study. Those who had early treatment were 33% less likely to be diagnosed with MS than those who received delayed treatment, according to the study.

“Overall, early treatment appears to have a benefit on relapses, especially early in the disease, but limited effects on other outcome measures, including outcomes reported by patients,” said Brian C. Healy, PhD, in the press release. Healy is on staff at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston and a member of the American Academy of Neurology, who wrote an accompanying editorial.

Results of the study showed that people in the early group had more time before their first relapse of the disease than people in the delayed group — 1,888 days compared with 931 days. The early group’s overall yearly relapse rate was 0.21 compared to 0.26 in the delayed group.

The April 2016 MD Magazine Peer Exchange video, “Importance of Early Intervention in Multiple Sclerosis” featured Patricia K. Coyle, MD, professor and vice chairwoman (Clinical Affairs) and director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University Medical Center, New York. “Virtually every single study has said that if you look at early treatment — as opposed to delayed treatment — and you look at late consequences, the early-treated groups are doing better,” she said in the video. “I think in a paradigm of accumulating permanent injury that is the best possibility of truly changing the natural history of the disease — to stop that damaged paradigm as much as you can in its tracks, early.”

According to the WebMD website, people may begin to show signs of the disease between ages 20 and 40. Sometimes several years can pass between episodes. The website lists MRI, spinal tap and evoked potentials as possible tests to diagnose the disease.

“Getting an MS diagnosis can be a lengthy process,” the website stated. “When some people finally learn they have the condition after months or years of symptoms, they take the news as something of a relief. For others, it can be shocking.”

The initial symptom often is blurred or double vision, red-green color distortion or even blindness in one eye, according to the American Academy of Neurology website. “Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance,” the website stated. “These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis.”

Story Source: The above story is based on materials provided by NURSE
Note: Materials may be edited for content and length


Go to Newer News Go to Older News